The blood-brain barrier (BBB), a collection of cells and subcellular structures in the cerebrovascular wall that separates the circulating blood from the brain, is essential to keep brain tissue in healthy condition. It regulates the delivery of important nutrients and blocks neurotoxins, while removing surplus substances from the brain. Now, a study from researchers has used contrast-enhanced MRI to identify leakages in the BBB of people with early Alzheimer’s disease (AD). The team state that their findings suggest increased BBB permeability may represent a key mechanism in the early stages of the disease.
Previous studies show blood-brain barrier leakage means that the brain has lost its protective means, the stability of brain cells is disrupted and the environment in which nerve cells interact becomes ill-conditioned. These mechanisms could eventually lead to dysfunction in the brain. The current study uses contrast-enhanced MRI to identify leakages in the blood-brain barrier of patients with early Alzheimer’s disease.
The current study used contrast-enhanced MRI to compare 16 early AD patients with 17 healthy age-matched controls. The lab measured BBB leakage rates and generated a map called a histogram to help determine the amount of the leaking brain tissue. Results show that the BBB leakage rate was significantly higher in AD patients compared with controls and the leakage was distributed throughout the cerebrum, the largest part of the brain. Data findings show that AD patients had a significantly higher percentage of leaking brain tissue in the gray matter, including the cortex, the brain’s outer layer.
The group state that they also found that measurements derived from the histogram showed very subtle BBB impairment in the brain’s white matter. Results show that a relationship between the extent of BBB impairment and decline in cognitive performance, suggesting that a compromised BBB is part of the early pathology of AD and might be part of a cascade of events eventually leading to cognitive decline and dementia. The lab note that the connection between BBB impairment and AD pathology was strengthened by the fact that the addition of diabetes and other non-cerebral vascular diseases to the analysis model did not change the results.
The team surmise that the key advantage of detecting BBB leakage with contrast MRI is that it can detect early microvascular changes in AD even in cases where no directly visible cerebrovascular abnormalities can be observed. For the future, the researchers state that for Alzheimer’s research, this means a novel tool has become available to study the contribution of blood-brain barrier impairment in the brain to disease onset and progression in early stages or pre-stages of dementia.
Michelle is a health industry veteran who taught and worked in the field before training as a science journalist.
Featured by numerous prestigious brands and publishers, she specializes in clinical trial innovation--expertise she gained while working in multiple positions within the private sector, the NHS, and Oxford University.